PROfound: Efficacy of olaparib (ola) by prior taxane use in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations
Author
Ozguroglu, Mustafa
De Bono, Johann S.
Fizazi, Karim
Saad, Fred
Shore, Neal D.
Roubaud, Guilhem
Penel, Nicolas
Matsubara, Nobuaki
Mehra, Niven
Procopio, Giuseppe
Kolinsky, Michael Paul
Nishimura, Kazuo
Feyerabend, Susan
Joung, Jae Young
Vogelzang, Nicholas J.
Carducci, Michael Anthony
Kang, Jinyu
Poehlein, Christian Heinrich
Wu, Wenting
Hussain, Maha H. A.
Metadata
Show full item recordCollections
- Bildiri [64839]